We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$9.31B
AUM Growth
+$1.38B
Cap. Flow
+$1.01B
Cap. Flow %
10.84%
Top 10 Hldgs %
57.26%
Holding
226
New
90
Increased
25
Reduced
49
Closed
45

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$589M
2
AGN
Allergan plc
AGN
+$492M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$231M
4
CY
Cypress Semiconductor
CY
+$185M
5
RHT
Red Hat Inc
RHT
+$124M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$383M
2
DIS icon
Walt Disney
DIS
+$196M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$186M
4
ARRS
ARRIS International plc Ordinary Shares
ARRS
+$132M
5
IDTI
Integrated Device Technology I
IDTI
+$129M

Sector Composition

Rank Sector Weight
1 Healthcare 15.64%
2 Technology 8.71%
3 Communication Services 5.59%
4 Industrials 3.72%
5 Materials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
151
DELISTED
Global Blood Therapeutics, Inc.
GBT
$601K 0.01%
+11,420
New +$656K
AMAL icon
152
Amalgamated Financial
AMAL
$1.5B
$592K 0.01%
33,897
– –
DOMO icon
153
Domo
DOMO
$182M
$589K 0.01%
21,571
-18,429
-46% -$640K
PS
154
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$518K 0.01%
17,100
-22,900
-57% -$735K
SCPL
155
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$473K 0.01%
+34,500
New +$511K
BCEL
156
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$471K 0.01%
+25,000
New +$451K
LINX
157
DELISTED
Linx S.A.
LINX
$456K ﹤0.01%
+50,000
New +$452K
STNE icon
158
StoneCo
STNE
$2.76B
$444K ﹤0.01%
+15,000
New +$441K
SRC
159
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$427K ﹤0.01%
+10,000
New +$422K
GE icon
160
CALL
GE Aerospace
GE
$399B
$420K ﹤0.01%
8,025
– –
WMGI
161
DELISTED
Wright Medical Group Inc
WMGI
$417K ﹤0.01%
14,000
-1,000
-7% -$30.5K
AVDR
162
DELISTED
Avedro, Inc Common Stock
AVDR
$409K ﹤0.01%
20,830
-19,170
-48% -$307K
CVS icon
163
CALL
CVS Health
CVS
$125B
$392K ﹤0.01%
+7,200
New +$388K
CVS icon
164
CVS Health
CVS
$125B
$392K ﹤0.01%
7,200
-7,176
-50% -$386K
CRWD icon
165
CrowdStrike
CRWD
$218B
$341K ﹤0.01%
+20,000
New +$340K
AAL icon
166
CALL
American Airlines Group
AAL
$11.2B
$326K ﹤0.01%
+10,000
New +$323K
NGM
167
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$309K ﹤0.01%
+21,100
New +$309K
ADPT icon
168
Adaptive Biotechnologies
ADPT
$3.93B
$290K ﹤0.01%
+6,000
New +$266K
CTST
169
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$249K ﹤0.01%
+49,700
New +$304K
SMAR
170
DELISTED
Smartsheet Inc.
SMAR
$242K ﹤0.01%
+5,000
New +$212K
NOMD icon
171
Nomad Foods
NOMD
$1.65B
$214K ﹤0.01%
10,000
-60,000
-86% -$1.26M
XRN
172
Chiron Real Estate Inc
XRN
$459M
$210K ﹤0.01%
4,000
-7,000
-64% -$366K
ESTC icon
173
Elastic
ESTC
$7.37B
$187K ﹤0.01%
2,500
– –
TW icon
174
Tradeweb Markets
TW
$21.8B
$175K ﹤0.01%
+4,000
New +$167K
HHR
175
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$163K ﹤0.01%
+10,000
New +$164K
5 6
7
8 9

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Pentwater Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Pentwater Capital Management held 226 positions worth $9.31B, up 17% from $7.93B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Pentwater Capital Management deployed $1.01B of net new capital in Q2 2019, opening 90 new positions and adding to 25 existing holdings. Its largest new stake was Anadarko Petroleum: 8,779,500 shares worth $619M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Celgene Corp, an estimated $383M trimmed.

  • Pentwater Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 8,779,500 shares worth $619M.
  • Pentwater Capital Management added most to Allergan plc in Q2 2019, an estimated $492M increase.
  • Pentwater Capital Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $383M.
  • Pentwater Capital Management fully exited Walt Disney in Q2 2019, selling an estimated $196M.
  • Pentwater Capital Management's ten largest holdings make up 57% of its $9.31B portfolio in Q2 2019.
  • Pentwater Capital Management opened 90 new positions and closed 45 in Q2 2019.
  • Pentwater Capital Management's portfolio value rose 17% quarter-over-quarter to $9.31B.

Based on Pentwater Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.